Recombinant Monkeypox Protein A29L Protein (His Marker): A Research Instrument
Recombinant Monkeypox Protein A29L Protein (His Marker): A Research Instrument
Blog Article
This produced Orthopoxvirus A29L molecule, featuring a His label, represents a significant scientific resource for investigation of viral functions and potential medicinal targets. The His tag facilitates for easy isolation and assessment using standard immobilized chromatography, making it appropriate for multiple experiments including immune association assays, structure analysis, and component production studies. Ultimately, Recombinant MPXV A29L Protein(His Tag) this engineered molecule offers a consistent way to advance knowledge of MPXV pathogenesis.
Production and Characterization of Recombinant MPXV A29L Protein (His Tag)
The optimized generation of recombinant MPXV A29L polypeptide, labeled with a His tag, was obtained using *E. coli* expression method. Initial attempts involved introducing the A29L DNA into a pet system followed by introduction into competent *E. coli* cells. Afterwards, improved growth conditions were defined to maximize output. Purification of the His-tagged A29L polypeptide was executed utilizing immobilized metal affinity chromatography. Characterization involved techniques such as SDS-PAGE, immunoblot blotting, and mass measurement to confirm identity and assess molecular weight and purity. The obtained recombinant A29L molecule exhibited appropriate weight and indicated the presence of the His label, validating adequate generation and isolation.
Purified Orthopoxvirus A29L Protein (His Tag|with a His-tag|His-tagged) for Monkeypox Virus Studies
The availability of purified MPXV A29L antigen (His Label) represents a valuable resource for advancing research into the mechanism of monkeypox virus. This protein facilitates easy detection and isolation through His chromatography, enabling for detailed analysis of its immunogenic properties, binding with host factors, and role in viral replication. The His tag serves as a convenient handle for easy generation and purification, rendering it ideally suited for the range of orthopoxvirus analyses.
Improving Synthesis of Produced MPXV A29L Factor (His Tag | with a His Tag | tagged with His | featuring a His tag)
To achieve efficient yields of the recombinant MPXV A29L factor , various conditions require meticulous adjustment . Early attempts involved routine synthesis in *E. coli*, however, this often resulted in low amounts and significant inclusion structure formation. Thus, strategies such as adjusting the signal strength, improving the growth settings, and employing aiding co-factors to assist proper conformation were employed . Besides, exploring alternative expression vehicles, such as fungi , is presently investigated to even boost production and refine factor integrity .
Applications of Recombinant MPXV A29L Protein (His Tag) in Diagnostics
Recombinant MPXV A29L molecule (His label) exhibits vital potential in improving reliable identification tests for MPXV infection. Its utilization as a epitope in ELISA and lateral flow devices enables for targeted binding of antibodies from infected patients. The His label simplifies cleansing and identification of the engineered A29L component, therefore improving the total functionality and selectivity of the diagnostic process. Further investigation into its inclusion into simultaneous diagnostic panels remains a hopeful field of investigation.
Recombinant MPXV A29L Antigen (His Tag) Stock and Specifications
The produced A29L molecule from Orthopoxvirus, featuring a His-tag for easy recovery, is now available for laboratory use. This particular product is synthesized in Escherichia coli and supplied as a powdered form, enabling for stable storage. Typical specifications include a weight of approximately 140 kDa, >90% cleanliness as assessed by sodium dodecyl sulfate polyacrylamide gel electrophoresis and a level of 1 mg/mL in a medium of salt solution. See the product guide for full specs regarding transport conditions and recommended keeping protocols.
Report this page